Home › Companies › ADMA BIOLOGICS INC. › 2023-2024
At ADMA BIOLOGICS INC.'s shareholder meeting held June 4, 2024, in the 2023-2024 proxy season, 73 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 837 separate fund positions. On the most widely held item on that ballot — To elect the following Class II directors for a term expiring at the 2027 Annual Meeting of… — FOR was 97% of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ADMA BIOLOGICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ADMA BIOLOGICS INC.’s Form 8-K, filed June 4, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 4, 2024: 4 items on ADMA BIOLOGICS INC.’s Form 8-K, filed June 4, 2024: 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore ADMA BIOLOGICS INC. in the interactive database Compare manager voting policies
These tallies are ADMA BIOLOGICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Steven A. Elms | 110,136,193 | -- | -- | 44,858,645 | 31,660,494 | 71% | Not verified | — |
| Elect Director: Adam S. Grossman | 150,349,105 | -- | -- | 4,645,733 | 31,660,494 | 97% | Not verified | — |
| Elect Director: Young T. Kwon, PhD | 152,744,777 | -- | -- | 2,250,061 | 31,660,494 | 99% | Not verified | — |
| 2. The ratification of the appointment of CohnReznick LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 184,478,528 | 1,983,914 | 192,890 | -- | -- | 99% | Not verified | — |
Source: ADMA BIOLOGICS INC., Form 8-K, filed with the SEC on June 4, 2024 — read the filing on EDGAR.
Each item below shows how the 73 asset managers that disclosed a ADMA BIOLOGICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect the following Class II directors for a term expiring at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Adam S. Grossman
ADMA BIOLOGICS INC.’s own tally for this item (“Elect Director: Adam S. Grossman”): 150,349,105 for, 4,645,733 withheld, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,226,385 | 0 | 0 | 0 | For |
| BlackRock | 9,255,562 | 0 | 0 | 0 | For |
| Invesco | 8,973,645 | 0 | 0 | 0 | For |
| State Street | 5,769,146 | 0 | 0 | 16,108 | For |
| TIAA | 5,736,629 | 0 | 0 | 0 | For |
| Fidelity | 4,624,292 | 0 | 0 | 0 | For |
| American Century | 3,544,076 | 0 | 0 | 0 | For |
| Nuveen | 3,091,496 | 0 | 0 | 0 | For |
| Dimensional | 2,877,769 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 2,790,700 | 0 | 0 | 0 | For |
| Charles Schwab | 1,780,542 | 0 | 0 | 0 | For |
| Federated Hermes | 1,604,170 | 0 | 0 | 0 | For |
| Calamos | 1,134,394 | 0 | 0 | 0 | For |
| SEI | 1,056,982 | 0 | 0 | 0 | For |
| MassMutual | 610,685 | 0 | 0 | 0 | For |
| Equitable | 580,683 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 430,216 | 0 | 0 | 0 | For |
| Allspring | 429,529 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 397,348 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 305,672 | 0 | 0 | 0 | For |
| Lincoln Financial | 284,124 | 0 | 0 | 0 | For |
| Russell Investments | 251,160 | 0 | 0 | 0 | For |
| MML Series Investment Fund II | 201,977 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 189,303 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 172,650 | 0 | 0 | 0 | For |
Fund voting reports, all 70 managers: 70,803,484 for, 16,108 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 1,540,000 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 9,377 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,549,377 for.
Combines 4 wordings of this item as funds reported it.
71% Majority: yes · of votes cast
Description as filed by funds: To elect the following Class II directors for a term expiring at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Steven A. Elms
ADMA BIOLOGICS INC.’s own tally for this item (“Elect Director: Steven A. Elms”): 110,136,193 for, 44,858,645 withheld, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,226,385 | 0 | 0 | 0 | For |
| BlackRock | 9,255,562 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 8,973,645 | Withhold |
| State Street | 176,605 | 0 | 0 | 5,608,649 | Withhold |
| TIAA | 0 | 0 | 0 | 5,736,629 | Withhold |
| Fidelity | 4,624,292 | 0 | 0 | 0 | For |
| American Century | 3,544,076 | 0 | 0 | 0 | For |
| Nuveen | 0 | 0 | 0 | 3,091,496 | Withhold |
| Dimensional | 2,877,769 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 2,790,700 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 1,780,542 | Withhold |
| Federated Hermes | 1,604,170 | 0 | 0 | 0 | For |
| Calamos | 1,134,394 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 1,056,982 | Withhold |
| MassMutual | 0 | 0 | 0 | 610,685 | Withhold |
| Equitable | 362,313 | 0 | 0 | 218,370 | Mixed |
| Direxion Shares ETF Trust | 430,216 | 0 | 0 | 0 | For |
| Allspring | 429,529 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 397,348 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 305,672 | 0 | 0 | 0 | For |
| Lincoln Financial | 106,224 | 0 | 0 | 177,900 | Mixed |
| Russell Investments | 251,160 | 0 | 0 | 0 | For |
| MML Series Investment Fund II | 0 | 0 | 0 | 201,977 | Withhold |
| Northern Lights Fund Trust IV | 189,303 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 172,650 | 0 | 0 | 0 | For |
Fund voting reports, all 70 managers: 42,954,742 for, 27,864,850 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 1,540,000 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 9,377 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,549,377 for.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect the following Class II directors for a term expiring at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Young T. Kwon
ADMA BIOLOGICS INC.’s own tally for this item (“Elect Director: Young T. Kwon, PhD”): 152,744,777 for, 2,250,061 withheld, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,226,385 | 0 | 0 | 0 | For |
| BlackRock | 9,255,562 | 0 | 0 | 0 | For |
| Invesco | 8,973,645 | 0 | 0 | 0 | For |
| State Street | 5,778,889 | 0 | 0 | 6,365 | For |
| TIAA | 5,736,629 | 0 | 0 | 0 | For |
| Fidelity | 4,624,292 | 0 | 0 | 0 | For |
| American Century | 3,544,076 | 0 | 0 | 0 | For |
| Nuveen | 3,091,496 | 0 | 0 | 0 | For |
| Dimensional | 2,877,769 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 2,790,700 | 0 | 0 | 0 | For |
| Charles Schwab | 1,780,542 | 0 | 0 | 0 | For |
| Federated Hermes | 1,604,170 | 0 | 0 | 0 | For |
| Calamos | 1,134,394 | 0 | 0 | 0 | For |
| SEI | 1,056,982 | 0 | 0 | 0 | For |
| MassMutual | 610,685 | 0 | 0 | 0 | For |
| Equitable | 580,683 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 430,216 | 0 | 0 | 0 | For |
| Allspring | 429,529 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 397,348 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 305,672 | 0 | 0 | 0 | For |
| Lincoln Financial | 284,124 | 0 | 0 | 0 | For |
| Russell Investments | 251,160 | 0 | 0 | 0 | For |
| MML Series Investment Fund II | 201,977 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 189,303 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 172,650 | 0 | 0 | 0 | For |
Fund voting reports, all 70 managers: 70,799,719 for, 19,873 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 1,540,000 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 9,377 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,549,377 for.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of CohnReznick LLP as the independent registered public accounting firm for the year ending December 31, 2024.
ADMA BIOLOGICS INC.’s own tally for this item (“2. The ratification of the appointment of CohnReznick LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 184,478,528 for, 1,983,914 against, per its Form 8-K filed June 4, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,226,385 | 0 | 0 | 0 | For |
| BlackRock | 9,255,562 | 0 | 0 | 0 | For |
| Invesco | 8,973,645 | 0 | 0 | 0 | For |
| State Street | 5,775,511 | 9,743 | 0 | 0 | For |
| TIAA | 5,736,629 | 0 | 0 | 0 | For |
| Fidelity | 4,624,292 | 0 | 0 | 0 | For |
| American Century | 3,544,076 | 0 | 0 | 0 | For |
| Nuveen | 3,091,496 | 0 | 0 | 0 | For |
| Dimensional | 2,877,769 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 2,790,700 | 0 | 0 | 0 | For |
| Charles Schwab | 1,780,542 | 0 | 0 | 0 | For |
| Federated Hermes | 1,604,170 | 0 | 0 | 0 | For |
| Calamos | 1,134,394 | 0 | 0 | 0 | For |
| SEI | 1,056,982 | 0 | 0 | 0 | For |
| MassMutual | 610,685 | 0 | 0 | 0 | For |
| Equitable | 580,683 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 430,216 | 0 | 0 | 0 | For |
| Allspring | 429,529 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 397,348 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 305,672 | 0 | 0 | 0 | For |
| Lincoln Financial | 284,124 | 0 | 0 | 0 | For |
| Russell Investments | 251,160 | 0 | 0 | 0 | For |
| MML Series Investment Fund II | 201,977 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 189,303 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 172,650 | 0 | 0 | 0 | For |
Fund voting reports, all 70 managers: 70,809,169 for, 10,423 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 1,540,000 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 9,377 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,549,377 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 231,809,197 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.27% |
| 2 | BlackRock | 3.99% |
| 3 | Invesco | 3.87% |
| 4 | State Street | 2.50% |
| 5 | TIAA | 2.47% |
| 6 | Fidelity | 1.99% |
| 7 | American Century | 1.53% |
| 8 | Nuveen | 1.33% |
| 9 | Dimensional | 1.24% |
| 10 | OBERWEIS FUNDS | 1.20% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Altium Capital Management LP | 0.66% |
| 2 | Jackson Creek Investment Advisors LLC | <0.01% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 15.37% | 13F |
| Vanguard Group | 9.05% | 13F |
| State Street | 4.55% | 13F |
| Nuveen | 4.51% | 13F |
| Invesco | 3.37% | 13F |
| D.E. Shaw | 2.32% | 13F |
| TIAA-CREF Investment Management, LLC | 2.14% | 13G |
| Geode Capital | 2.07% | 13F |
| Two Sigma | 1.66% | 13F |
| Adam S. Grossman | 1.63% | DEF14A |
Percentages above are of 231,809,197 shares outstanding, as reported by ADMA BIOLOGICS INC. on its Form 10-Q dated May 3, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADMA BIOLOGICS INC.’s 10-Q dated May 3, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
ADMA BIOLOGICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “ADMA BIOLOGICS (ADMA) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/adma-biologics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.